Advertisement

Topics

Suono Bio Names Lisa Ricciardi CEO, Carl Schoellhammer Becomes COO

14:52 EDT 14 Sep 2018 | Xconomy

Lisa Ricciardi has been appointed CEO of Cambridge, MA-based Suono Bio. Founding CEO Carl Schoellhammer will shift to chief operating officer and board member. Ricciardi’s experience includes various roles at companies such as Pfizer (NYSE: PFE), Medco, and Foundation Medicine. Suono, an MIT spinout, is developing technology that uses ultrasound to improve drug delivery.

Original Article: Suono Bio Names Lisa Ricciardi CEO, Carl Schoellhammer Becomes COO

NEXT ARTICLE

More From BioPortfolio on "Suono Bio Names Lisa Ricciardi CEO, Carl Schoellhammer Becomes COO"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Pfizer
Pfizer is a global pharmaceutical company, the largest in world based on annual sales.  In 2009, annual sales were worth $45,448m. Pfizer spend £550m on R&D in the UK alone, and have colleagues in 180 countries. Lipitor, one of its produ...

Radiology
Radiology is the branch of medicine that studies imaging of the body; X-ray (basic, angiography, barium swallows), ultrasound, MRI, CT and PET. These imaging techniques can be used to diagnose, but also to treat a range of conditions, by allowing visuali...

Drug Delivery
<!--LGfEGNT2Lhm-->Drug delivery is the method or process of administering a pharmaceutical compound to achieve a therapeutic effect in humans or animals.  <!--LGfEGNT2Lhm-->Drug delivery technologies are <!--LGfEGNT2Lhm-->patent pr...